Pharmacogenomics in pulmonary arterial hypertension (PAH): the relationship between an ET-1 gene polymorphism (PM) and efficacy of bosentan (BO)

Abstract

Peer reviewed

R.L Benza, G.S Mohanty, H.E Grenett, C.S Coffey, B.K Rayburn, J.A Tallaj, M.A Law, L.J Pinderski, S.V Pambokian and R.C Bourge

The Journal of heart and lung transplantation, Vol.23(2), pp.S146-S146

2004

DOI: 10.1016/j.healun.2003.11.308

View Online

Title: Subtitle: Pharmacogenomics in pulmonary arterial hypertension (PAH): the relationship between an ET-1 gene polymorphism (PM) and efficacy of bosentan (BO)
Creators: R.L Benza - Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
G.S Mohanty - Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
H.E Grenett - Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
C.S Coffey - Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA
B.K Rayburn - Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
J.A Tallaj - Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
M.A Law - Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
L.J Pinderski - Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
S.V Pambokian - Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
R.C Bourge - Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
Resource Type: Abstract
Publication Details: The Journal of heart and lung transplantation, Vol.23(2), pp.S146-S146
Publisher: Elsevier Inc
DOI: 10.1016/j.healun.2003.11.308
ISSN: 1053-2498
eISSN: 1557-3117
Language: English
Date published: 2004
Academic Unit: Biostatistics
Record Identifier: 9984214686902771

3 Record Views